Dublin, March 02, 2022 (GLOBE NEWSWIRE) -- The "Hepatitis Diagnostic Tests Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
The global hepatitis diagnostic tests market reached a value of US$ 5.3 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 7.24 Billion by 2027, exhibiting a CAGR of 5.25% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Hepatitis represents a major global health threat that requires an urgent response. According to estimates, hepatitis causes 1.3 Million-1.5 Million deaths each year, a figure that is comparable to the deaths caused by tuberculosis and even higher than those caused by HIV. Moreover, while mortality from diseases such as HIV, tuberculosis, and malaria are now declining, mortality from hepatitis has been rising. According to estimates around 325-350 Million people across the globe are carriers of hepatitis B or C virus infections, which may remain asymptomatic for decades. Moreover, every year, around 1.75 Million people get infected by the hepatitis C virus infection. Unless these people receive timely testing and treatment, they are at risk of severe liver disease and even death. Diagnostic tests help in the early detection of hepatitis infections and increase the chances of survival of the patient by correct medication and treatment.
The global demand of hepatitis diagnostic tests is currently exhibiting strong growth. This market is currently being catalyzed by a number of factors such as the increasing burden of hepatitis across the globe, rising number of blood transfusions and donations, technological advancements and the advantages offered by PoC (Point of Care) test, and rising awareness levels. A major trend being witnessed in this market has been a shift from conventional testing methods to molecular diagnostics. This has resulted in an increased accuracy and reduced the total time required to get the results.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global hepatitis diagnostic tests market, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on test type.
Breakup by Test Type:
- Blood Tests
- Imaging Test
- Liver Biopsy
Based on the test type, the market has been segmented into blood tests, imaging test and liver biopsy. Blood tests currently represent the biggest application. Blood tests are further segmented into liver function test, immunoassays, and nucleic acid tests. Liver function tests currently represent the biggest segment.
Breakup by Region:
- North America
- Asia Pacific
- Europe
- Middle East and Africa
- Latin America
Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa and Latin America. Amongst these, North America is the biggest market, accounting for the majority of the global market.
Competitive Landscape:
The competitive landscape of the market has also been examined with some of the key players being Siemens AG, Abbott Laboratories, MedMira Inc, Qiagen Inc, Beckman Coulter Inc (Danaher Corporation), F. Hoffmann Roche, Diasorin S.p.A, bioMerieux, Hologic Inc and Bio-Rad Laboratories Inc.
Key Questions Answered in this Report:
- How has the global hepatitis diagnostic tests market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global hepatitis diagnostic tests industry?
- What has been the impact of COVID-19 on the global hepatitis diagnostic tests industry?
- What is the breakup of the global hepatitis diagnostic tests market on the basis of test type?
- What are the various stages in the value chain of the global hepatitis diagnostic tests market?
- What are the key driving factors and challenges in the global hepatitis diagnostic tests market?
- What is the structure of the global hepatitis diagnostic tests market and who are the key players?
- What is the degree of competition in the global hepatitis diagnostic tests market?
Key Topics Covered:
1 Preface
2 Scope and Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Hepatitis Diagnostic Tests Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Test Type
5.5 Market Breakup by Region
5.6 Market Forecast
5.7 SWOT Analysis
5.8 Value Chain Analysis
5.9 Porters Five Forces Analysis
5.10 Price Analysis
6 Market Breakup by Test Type
6.1 Blood Tests
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Imaging Test
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Liver Biopsy
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Region
8 Competitive Landscape
8.1 Market Structure
8.2 Key Players
8.3 Profiles of Key Players
8.3.1 Siemens AG
8.3.2 Abbott Laboratories
8.3.3 MedMira Inc
8.3.4 Qiagen Inc
8.3.5 Beckman Coulter Inc (Danaher Corporation)
8.3.6 F. Hoffmann Roche
8.3.7 Diasorin S.p.A
8.3.8 bioMerieux
8.3.9 Hologic Inc
8.3.10 Bio-Rad Laboratories Inc
For more information about this report visit https://www.researchandmarkets.com/r/kmzfsu
Attachment
